To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Objectives/Goals: 1. To develop UgS and UgF in CTR with IA in PR. 2. To equip UgS and UgF with the necessary knowledge, skills, and mentoring and provide hands-on experiences for their academic and professional development. 3. To provide UgS and UgF with dissemination opportunities. Methods/Study Population: Main approaches: Restructure the Center for Research Education and Science Communication Opportunities (CRESCO), hub to provide support in CTR skills, statistics, scientific writing, and access to library resources; and organize/launch a training program in CTR to support student development in CTR. Main strategies: peer-mentoring with graduate students (GS), faculty (F), and health professionals (HP); a pilot project (PiP) program to offer UgS, GS, F, and HP hands-on experiences with participation in up-to-date research in CTR under the mentorship of a principal investigator-mentor; organization/offering the Title V Annual Symposium in CTR as a dissemination platform; and acquisition of supplies/equipment to support the research and infrastructure to the library and academic programs. Results/Anticipated Results: CRESCO: Acquired 2-96’ interactive monitors and refurbished 7 study rooms with technology, boosting distance learning. Developed a Web portal, offered 27,249 consultations, and 692 attended CTR workshops. Training program: INTD 5998 course had 74 students (64 UPR-MSC and 10 from other campuses/institutions). 190 Orientations offered to Academic Program in Health Sciences (APHS), reaching 36 departmental chairs (dc) and 129 UgS from 10 UPR campuses, and 23 dc and 2 UgS from other universities. Healthcare associations approved one Continuing Education Module, and two were submitted for approval. PiP: 32 PiP teams (32 primary researchers, 32 UgF, 42 UgS, and 21 GS) from 9 institutions. Presented 38 oral/poster presentations (27 PiPs, 11 Collaborators) and published 4 peer-reviewed publications. Discussion/Significance of Impact: The project strengthened CTR research/education through CRESCO facilities, consultations, and training. The INTD 5998 course, APHS orientations, and PiP teams (from diverse campuses/institutions), expanded participation and hands-on experience, yielding presentations, publications, UgS seeking graduate studies, and real-world impact.
Objectives/Goals: We aim to clarify the role of the intestinal tuft cell-acetylcholine (ACh)-muscarinic receptor axis in inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC) and to investigate whether altering tuft cell activity impacts colitis severity and CAC. Methods/Study Population: (1) To characterize tuft cell distribution in intestinal tissues of humans with and without IBD and CAC, we will use immunohistochemistry, RNAscope, and in situ hybridization. (2) In mice treated with dextran sodium sulfate (DSS) to induce colitis, we will use indolepropionic acid and succinate to manipulate intestinal tuft cell numbers. We will derive enteroids from these and control mice and compare tuft cell numbers, ACh synthetic markers, and anti- and pro-inflammatory cytokines. (3) We will compare the effects of altered tuft cell populations on colitis severity and tumor number and size in mice treated with or without DSS/azoxymethane to induce colitis and CAC. Results/Anticipated Results: Intestinal tuft cells are key participants in anti-inflammatory signaling. Hence: (1)compared to tissue from healthy controls, we anticipate finding altered tuft cell distribution and fewer tuft cells in intestinal tissues from humans with IBD and CAC; (2) compared to controls, intestinal enteroids from mice treated with indolepropionic acid or succinate prior to DSS treatment will retain more tuft cells and an augmented anti-inflammatory cytokine signature; (3) mice with augmented tuft cell numbers will exhibit attenuated colitis and CAC. Discussion/Significance of Impact: Interplay between gut immune and epithelial cells, neurons, and the microbiome underlies colitis. Current therapies target only immune cells, with limited efficacy. Studying other players in IBD pathogenesis, like tuft cells, is likely to reveal novel therapeutic targets.
Objectives/Goals: The aging (65+) population is rapidly growing and faces unique health issues exacerbated by immune function decline. However, the driving mechanisms behind this decline are poorly understood. We will use a mouse model to study the relationship between stiffness and cell mobility within the lymph node (LN) as one potential driving mechanism. Methods/Study Population: We will collect inguinal LNs from young (6–8 weeks) and aged (18+ months) female mice and section them for ex vivo analysis, including quantification of proteins in the fibroblastic reticular network (collagen I, collagen III, collagen VI, laminin, and fibronectin) using immunofluorescent staining and Python scripts; analysis of biomechanical properties (elastic modulus, loss modulus, and pore size) using multiple particle tracking (MPT); and migration analysis of adoptively transferred B- and T-cells using live imaging and MATLAB scripts. We will use ANOVA to compare abundance and organization of proteins, biomechanical properties, and cell migration between young and aged LNs, as well as using Pearson’s correlation coefficients to identify relationships between characteristics. Results/Anticipated Results: We hypothesize a positive correlation between fibroblastic reticular network protein deposits, especially collagens, and stiffness (elastic modulus) within murine LNs due to known mechanisms underlying age-related fibrosis. We also hypothesize that areas of increased stiffness (as revealed by MPT) will exhibit decreased cell migration due to physical hindrance to B- and T-cell mobilization. Furthermore, we hypothesize that aged murine LNs will exhibit a significant increase in stiffness and resultant decreased cell mobility when compared to young murine LN, particularly in areas with increased collagen localization. Discussion/Significance of Impact: These studies will elucidate structure–function relationships driving age-associated LN fibrosis and stiffness, and the resultant effect on cell migration, thus clarifying some of the potential driving mechanisms behind immune aging and providing data capable of informing the development of relevant models, therapeutics, and interventions.
Objectives/Goals: In psychosis spectrum disorders, diffusion tensor imaging studies consistently report reduced fractional anisotropy in the superior longitudinal fasciculus, a major tract linking frontal and parietal cortices, yet the neurochemical underpinnings of these microstructural abnormalities remain poorly understood. Methods/Study Population: We collected diffusion MRI scans and single-voxel PRESS magnetic resonance spectroscopy scans both in parietal and frontal white matter in 48 medication naïve patients and 39 healthy controls. Fractional anisotropy within the superior longitudinal fasciculus was quantified in using TORTOISE and compared with frontal and parietal neurometabolic profiles processed with LC model and partial volume corrected. Results/Anticipated Results: Myoinositol and TNAA were significantly different between patients and controls in both frontal and parietal white matter. Fractional anisotropy of the superior longitudinal fasciculus was significantly different between patients and controls. Both myoinositol and TNAA were associated with superior longitudinal fasciculus fractional anisotropy when modeled independently, but when jointly modeled only TNAA was significantly associated with fractional anisotropy in the parietal white matter while only myoinositol was significant in the frontal white matter. Both parietal and frontal white matter had a significantly greater association between myoinositol and fractional anisotropy than controls. Discussion/Significance of Impact: Disruptions in neuronal integrity and glial dysfunction likely contribute to decreased fractional anisotropy in frontoparietal white matter in first-episode psychosis spectrum disorders. These disturbances are not related to medication effects.
Edited by
Katherine Warburton, California Department of State Hospitals, University of California, Davis, USA,Stephen M. Stahl, University of California, Riverside, USA
This chapter explores the historical evolution of the nomenclature of schizophrenia and the shift towards understanding it as a multi-systemic disease state with significant physical health implications. It highlights the elevated prevalence of cardiometabolic disorders in individuals with schizophrenia, including obesity, diabetes, metabolic syndrome, and liver diseases. These conditions not only contribute to overall illness burden and morbidity but also exacerbate the underlying brain disturbance in schizophrenia. The chapter emphasizes the need for integrated care that prioritizes both mental and physical health to address the disparities in healthcare access and outcomes faced by individuals with schizophrenia. It calls for frameworks of care and prevention, supported by adequate funding and access to high-quality care, to address the treatable and preventable cardiometabolic disorders that significantly impact the quality and duration of life for those living with schizophrenia.
1. Patients with tracheostomy bleeding can decompensate rapidly and a difficult airway should be expected. To prepare, advanced airway equipment should be gathered, and ENT and respiratory therapy should be notified.
2. Tracheoinnominate fistulas (TIF) have a high mortality rate and up to 50% are heralded by a sentinel bleed; therefore, all tracheostomy bleeds should be worked up for TIF unless the source of bleed is obviously local to the stoma and source is visualized.
3. Clinical red flags suggesting TIF include blood in the oropharynx, pressurized or large-volume bleeding, or trach pulsations in time to the patient’s heartbeat.
4. Imaging with CTA neck and chest is indicated for surgical planning only in hemodynamically stable patients.
5. Attempts to tamponade a tracheostomy bleed should include, first, cuff hyperinflation and, second, blunt finger dissection and compression of the innominate artery. Patients with TIF ultimately need operative correction or else they are certain to rebleed.
Survivors are not a random sample of patients with disease, they are biased. How they differ from non-survivors must be understood before survival can be attributed to a disease process, or therapeutic intervention. Live-birth bias is a particular example; many conceptions fail before term birth and this influences the live-birth population. The importance of collider bias is reviewed. Workers are generally healthier than those not working introducing bias into occupational health studies.
1. Acute coronary syndrome (ACS) with thrombocytopenia can arise from malignancy or treatment related complications.
2. Cancer patients with ACS can have atypical symptoms.
3. Therapy will need to dynamically adapt to the patient's platelet count and other risk factors.
4. Do not hold PCI for ACS patients with slight to moderate thrombocytopenia.
5. Prophylactic platelet transfusion is generally reserved for very low counts (often <10,000/µL). However, higher thresholds may be used in patients with fever or other risk factors. Collaboration with Hematology-Oncology is recommended when available.
1. Veno-occlusive disease (VOD) is a complication of Hematopoietic stem cell transplant (HSCT) with significant morbidity and mortality among transplant recipients
2. VOD involves damage to sinusoidal endothelial cells and hepatocytes leading to liver dysfunction.
3. Early recognition and diagnosis using the modified Seattle or Baltimore criteria is crucial.
4. Defibrotide is the only approved treatment for severe VOD and is effective when initiated early.
5. The prognosis of VOD depends on severity of the condition and the timeliness of intervention.
Edited by
Katherine Warburton, California Department of State Hospitals, University of California, Davis, USA,Stephen M. Stahl, University of California, Riverside, USA
This study explores the effectiveness of antipsychotic medications in restoring competency to stand trial in individuals with severe mental illness, particularly psychotic disorders. While antipsychotic medications are known for reducing symptoms of psychosis, this research focuses on their ability to improve functional outcomes necessary for competency to stand trial (CST). Among over 3,000 patients in California’s forensic state hospital system, 86.5% were successfully restored to competency, with 98.8% discharged on antipsychotic medications. Patients on antipsychotic monotherapy demonstrated higher restoration rates compared to those requiring additional mood stabilizers, suggesting that more complex cases demand more intensive treatment. Delusional disorder, traditionally seen as more resistant to treatment, showed a high restoration rate of 93.8% with antipsychotic use.Our findings emphasize the pivotal role of antipsychotics in not only reducing symptoms but also in restoring critical functional abilities for participation in legal proceedings. The functional improvements they enable extend beyond the courtroom. Incorporation of antipsychotic medication as an integral evidence-based mechanism in facilitating community reintegration for individuals with severe mental illness supports the broader goal of transitioning individuals from the legal system back into society, consistent with the ultimate promise of deinstitutionalization.
1. Patients with advanced cancer can develop ureteric obstruction and percutaneous nephrostomy tube insertion can relieve this obstruction and prevent renal failure
2. Survival in patients with malignant ureteral obstruction can range widely from a few days to a few years.
3. Nephrostomy tube placement is generally safe and without major complications, however, patients with nephrostomy tubes often present to the ED with a wide array of complications.
4. It is important to have a high index of suspicion for infectious etiologies in nephrostomy tube complications, especially in patients with cancer.
5. Laboratory and imaging studies, along with specialty consultation are often needed to troubleshoot many nephrostomy tube complications.
1. Patients should be screened for potential risk factors of cardiac toxicity and should receive care from a cardiologist, ideally one specializing in oncology. Dose adjustments, active cardiac surveillance, awareness of potential effects, and expert consultation early in the management of cancer are all effective measures for prevention of cancer treatment induced cardiac side effects.
2. Patients with diagnosed dysrhythmias may require prolonged monitoring with ambulatory recorders and possibly oncology specific cardiology follow up.
3. Standard therapy should be used to initially treat chemotherapy-associated ventricular dysrhythmia. Mexiletine may be the preferred antidysrhythmic due to dosing and mechanism.
4. Some dysrhythmias may abate after withdrawal of offending agent, but some dysrhythmias may be permanent and necessitate AICD placement
5. For patients who are administered IV fluid hydration, choice of fluids should be based on the risk associated with increased electrolyte content of non-isotonic solutions.
Complex CHDs may impair organ development. One proposed mechanism is an altered relationship between blood flow, oxygen delivery, and subsequent organ growth. In this study, we examined whether fetal lung, intracranial, liver, and kidney volumes differ among fetuses with transposition of the great arteries with an intact ventricular septum, transposition of the great arteries with a ventricular septal defect, and healthy controls.
Methods:
Eleven fetuses with transposition of the great arteries (6 with a ventricular septal defect and 5 with an intact ventricular septum) and 22 healthy controls were scanned between 1 and 3 times at gestational age 27–38 weeks, using fetal MRI. We measured lung, total intracranial, liver, and kidney volumes and compared fetuses with and without transposition of the great arteries while subsequently correcting for ventricular septal defect/intact ventricular septum status, estimated fetal weight, and gestational age, using mixed effects regression analysis.
Results:
Fetuses with transposition of the great arteries+intact ventricular septum had significantly larger lung volumes compared to controls. After adjusting for estimated fetal weight and gestational age, median lung volume ratio (transposition of the great arteries+intact ventricular septum vs. controls) was 1.30 (95% CI: 1.08–1.57; p = 0.005). No difference was found in lung volume between fetuses with transposition of the great arteries+ventricular septal defect and controls. No significant differences in total intracranial, liver, and kidney volumes were found between transposition of the great arteries+ventricular septal defect, transposition of the great arteries+intact ventricular septum, and controls.
Conclusion:
In this preliminary study, late-gestation fetuses with transposition of the great arteries-intact ventricular septum had a 30% larger lung volume compared with both transposition of the great arteries-ventricular septal defect and healthy controls. Together with existing evidence of higher fetal pulmonary blood flow and increased oxygen saturation in transposition of the great arteries-intact ventricular septum, these findings support a potential link between blood flow, oxygen delivery, and organ growth.
Edited by
Katherine Warburton, California Department of State Hospitals, University of California, Davis, USA,Stephen M. Stahl, University of California, Riverside, USA
Schizophrenia is known to be a disabling psychiatric condition with wide reaching impact on everyday functioning and outcomes. These functional outcomes include increases in all-cause mortality (especially suicide and injury), cognitive and functional capacity deficits, lower reported levels of quality of life, increased incarceration, higher risk for violence and victimization, and homelessness. Studies have shown that medications and outpatient services can improve each of these functional outcomes in individuals with schizophrenia. However, most studies of pharmacological treatment utilize rating scales which do not reflect the real-world outcomes. This review looks at available studies focused on real-world outcomes and argues for an expansion of this body of research.
1. Radiation-induced pulmonary fibrosis (RPF) is a chronic respiratory complication that typically arises around six months to years after radiation therapy. It is characterized by progressive dyspnea due to lung scarring, potentially leading to chronic pulmonary insufficiency, pulmonary hypertension, and cor pulmonale.
2. Chronic radiation injury, usually emerging 6-12 months after treatment, causes vascular damage in the intestines, leading to fibrosis, ischemia, and various gastrointestinal problems such as obstructions, strictures, and fistulae.
3. Chronic proctitis from radiation injury typically emerges at six to 12 months post-radiation treatment and causes vascular damage within the intestine leading to fibrosis, ischemia, and various gastrointestinal problems such as obstruction, stricture, and fistula.
4. Pericardial disease is the most common form of radiation-induced heart disease (RIHD), but usually is a diagnosis of exclusion. Treatment is similar to that for non-radiation induced heart disease but often with a poorer prognosis.
5. The mandible is highly susceptible to radiation damage, osteoradionecrosis (ORN) is the most critical complication post-treatment with management starting conservatively with saline irrigation, antibiotics, and hyperbaric oxygen therapy and surgical interventions considered for advanced cases.
1. It is important to check coagulation parameters and review the peripheral smear in patients with acute promyelocytic leukemia (APL) in the differential diagnosis.
2. Patients with APL are at risk for increased early mortality from catastrophic bleeding.
3. Thrombotic events are less common but can occur.
4. It is essential to consult Hematology/Oncology in the ED to start all-trans retinoic acid (ATRA) as soon as possible.
5. Consider differentiation syndrome in APL patients started on ATRA treatment who present clinically with findings such as fever, weight gain, respiratory distress, and peripheral edema and workup concerning for new pulmonary infiltrates, pericardial effusion, hypotension, or renal failure
Edited by
Katherine Warburton, California Department of State Hospitals, University of California, Davis, USA,Stephen M. Stahl, University of California, Riverside, USA
1. Keep the SPIKES mnemonic in mind to guide difficult conversations regarding bad news.
2. Prior to conversation, prepare yourself to guide the conversation, find a quiet, undisturbed setting, and allow for time to answer questions following news delivery.
3. Approach each patient with sensitivity and compassion. Acknowledge the gravity of the situation and validate emotions.
4. When delivering news, use clear, direct language. Avoid medical jargon or complicated terminology.
5. Tailor news delivery according to emotions displayed by patient and family. Give patients and families time to process information, discuss amongst themselves, and return to answer questions as they crop up.
Edited by
Katherine Warburton, California Department of State Hospitals, University of California, Davis, USA,Stephen M. Stahl, University of California, Riverside, USA